Fecal microbiota transplantation and microbiota‐based therapeutics in pediatric clinical practice: Current status and emerging indications
Journal of Pediatric Gastroenterology and Nutrition · 2026-11-05
DOI: 10.1002/jpn3.70633 ↗Abstract
Abstract Fecal microbiota transplantation (FMT) is a safe and effective treatment for recurrent or refractory Clostridioides difficile infection (rCDI) in children and adults. This review outlines the evidence behind FMT for rCDI, considerations in special pediatric populations, and limitations in current practice due to FMT access for patients under the age of 18.
EUVIMED